Sands Capital Ventures as of Dec. 31, 2021
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 16 positions in its portfolio as reported in the December 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Uipath Com Cl A (PATH) | 24.4 | $164M | 3.8M | 43.13 | |
| Doordash Com Cl A (DASH) | 13.3 | $90M | 602k | 148.90 | |
| Nu Holdings Com Cl A (NU) | 12.7 | $86M | 9.1M | 9.38 | |
| Dice Therapeutics | 11.8 | $80M | 3.1M | 25.31 | |
| Samsara Com Cl B | 11.3 | $76M | 2.7M | 28.11 | |
| Snowflake Com Cl A (SNOW) | 10.8 | $73M | 215k | 338.75 | |
| Karuna Therapeutics Ord | 5.2 | $35M | 268k | 131.00 | |
| Acumen Pharmaceuticals (ABOS) | 3.4 | $23M | 3.4M | 6.76 | |
| Samsara Com Cl A (IOT) | 1.4 | $9.2M | 326k | 28.11 | |
| 908 Devices (MASS) | 1.3 | $8.4M | 326k | 25.87 | |
| Taysha Gene Therapies (TSHA) | 1.3 | $8.4M | 725k | 11.65 | |
| Candel Therapeutics (CADL) | 0.9 | $6.3M | 812k | 7.82 | |
| Repligen Corporation (RGEN) | 0.9 | $6.0M | 23k | 264.86 | |
| Tarsus Pharmaceuticals (TARS) | 0.9 | $5.9M | 260k | 22.50 | |
| Spruce Biosciences (SPRB) | 0.5 | $3.5M | 787k | 4.46 | |
| Absci Corp (ABSI) | 0.1 | $474k | 58k | 8.20 |
